Study Reveals Controlling Blood Sugar Halves Heart Disease Risk

Research indicates that individuals with prediabetes who manage their blood sugar levels effectively can significantly reduce their risk of death from heart disease or heart failure. A study published on December 12, 2023, in the journal Lancet Diabetes & Endocrinology, found that those achieving normal glucose levels, termed “remission,” had a 50 percent lower risk of cardiovascular mortality or hospitalisation due to heart failure compared to those who did not reach this benchmark.

Prediabetes affects approximately 38 percent of adults in the United States, characterized by elevated blood sugar levels that do not yet qualify as diabetes. This condition has long been associated with an increased risk of cardiovascular issues, but the direct relationship between prediabetes and heart disease has only recently come into clearer focus.

The study followed participants from the US Diabetes Prevention Program, which ran from 1996 to 2001. This program investigated the effects of various interventions on the onset of Type 2 diabetes. Participants engaged in either an intensive lifestyle program focused on diet and exercise, received the medication metformin, or were given a placebo. Remarkably, the intensive lifestyle approach resulted in a 58 percent reduction in the development of Type 2 diabetes over three years, while metformin lowered the risk by 31 percent.

Two decades later, approximately 11 percent of participants in the lifestyle intervention group had returned to normal glucose levels. This group showed a 50 percent decreased risk for cardiovascular-related death and hospitalisation for heart failure, even after adjusting for variables like the development of full-blown diabetes.

To corroborate these findings, researchers conducted additional analyses using data from a similar diabetes prevention trial in China. In this trial, 13 percent of participants achieved normal glucose levels after six years, and 30 years later, they had a 51 percent lower risk of cardiovascular death or hospitalisation compared to their counterparts who did not reach normal levels.

Dr. Latha Palaniappan, an associate dean for research at Stanford Medicine, emphasized the significance of these findings, stating, “That is an incredible finding and really gives people hope that what they do today will have an effect two decades from now.”

While the results are promising, they highlight a critical challenge: very few individuals manage to achieve normal glucose levels through the interventions studied. Judy Regensteiner, director of the Ludeman Family Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus, noted that the low success rates in both trials raise questions about how to enhance outcomes.

Experts advocate for comprehensive management of cardiovascular risk, emphasizing that lowering blood glucose is just one aspect of the equation. Maintaining a healthy weight, adhering to a balanced diet, and engaging in regular physical activity remain crucial components in mitigating heart disease risk.

Dr. Andreas Birkenfeld, chair of the department of diabetology, endocrinology, and nephrology at University Hospital Tubingen in Germany, pointed out that normalizing glucose levels can lead to reductions in abdominal fat, decreased inflammation, and improved insulin sensitivity. He noted that these factors collectively contribute to a lower risk of heart disease.

As the research continues to evolve, the integration of new therapeutic options, such as GLP-1 drugs, may offer additional strategies in managing blood sugar levels and overall cardiovascular health. Dr. Elizabeth Selvin from the Johns Hopkins Bloomberg School of Public Health stated, “Lifestyle interventions are first-line therapy. The real open question is, how do we combine these two things?”

In summary, while the study provides compelling evidence that controlling blood sugar can significantly reduce heart disease risk, it also underscores the importance of a multifaceted approach to health management. As experts continue to investigate the implications of these findings, the focus remains on encouraging proactive measures to manage prediabetes and its potential consequences.